[ASBMT logo]













 

10 Young Clinicians, Investigators

Selected for ASBMT Training Course

 

Ten new clinicians and investigators have been selected to participate in the first ASBMT Transplant Clinical Research Training Course, to be held in mid-July in Keystone, Colo. 

 

The six-day course is designed to assist fellows and young faculty in career paths toward successful clinical research in blood and marrow transplantation.  The participants were selected competitively from among 30 submitted applications, each including a proposed research project. 

 

Major funding for the clinical research training course is being provided by Amgen, Merck, PDL BioPharma, Genzyme Transplant and Abbott Molecular.

 

The fellow-in-training participants will be:

                                                                                   

Ann Mullally, MD, Massachusetts General Hospital, Boston

Phillippe Armand, MD, PhD, Dana-Farber, Boston

Carlos Almeida Ramos, MD, M.D. Anderson, Houston

Alana Kennedy-Nasser, MD, Baylor, Houston

Kirsten Williams, MD, National Cancer Institute, Bethesda

Jeanne Palmer, MD, Duke, Durham

Guillermo J. Ruiz Delgado, MD, Hospital Universitario, 
    Monterrey, Mexico

 

The junior faculty participants will be:

 

Guenther Koehne, MD, PhD, Memorial Sloan-Kettering, 
    New York

Carrie Kitko, MD, University of Michigan, Ann Arbor

G. Doug Myers, MD, Baylor, Houston

 

The course directors are Daniel Weisdorf, MD, of the University of Minnesota, and Nelson Chao, MD, of Duke University.  They, together with six other faculty members, will lead the sessions, as well as share their career stories and counsel.  Free time for rest, recreation and creative thinking is built into the schedule.

 

The concept of a clinical research training course emanated from an ASBMT Board of Directors strategic planning retreat.  “The board members felt that existing fellowship programs don’t adequately train clinical fellows in the principles of clinical research in blood and marrow transplantation,” said Armand Keating, MD, past-president and chair of the committee to develop the training course. 

 

“Training programs typically don’t fully cover the principles of taking basic research findings from the laboratory to the clinic, nor do they adequately prepare the best young physicians for academic careers in blood and marrow transplantation.  We expect the training course to address those deficiencies and help close the gap,” he said.

The faculty members for the transplant clinical research training course are:

 

·    Chris Bredeson, MD, MSc, Medical College of Wisconsin – clinical trial development, monitoring and data management

·    Dr. Chao – mechanisms of GvHD, graft manipulation, animal models and grant writing/grantsmanship

·   Corey Cutler, MD, MPH, Dana-Farber Cancer Institute – GvHD, new drug studies and translational studies

·     Armand Keating, MD, Princess Margaret Hospital Cancer Center, Toronto – stem cell biology, gene therapy and translational studies

·    Ginna Laport, MD, Stanford University – cancer trials, new agents and multicenter trials

·    Stephanie Lee, MD, MPH, Fred Hutchinson Cancer Research Center – quality of life/late effects

·    Brent Logan, PhD, Center for International Blood and Marrow Transplant Research – statistics

·     Jeffrey Miller, MD, University of Minnesota –  cellular and molecular mechanisms of immunologic anti-cancer therapy

·    Dr. Weisdorf – GvHD clinical and translational trials and complications of transplant